JENELLE WALLIS: Open Payments
NPI 1386279032 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 37 payments from 10 companies in 2025. Trend: 2023 $482 · 2024 $377 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $267 |
| Novartis Pharmaceuticals Corporation | 11 | $189 |
| BridgeBio Pharma, Inc. | 4 | $69 |
| Kestra Medical Technology Services, Inc. | 1 | $41 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Novo Nordisk Inc | 1 | $20 |
| AtriCure, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: JARDIANCE, LEQVIO, Attruby, Assure WCD, AMVUTTRA, VERQUVO, Wegovy, ATRICLIP LAA EXCLUSION SYSTEM.
Industry payments across AR — which companies pay providers there.
